POSTED : June 4, 2019
BY : Ryan Riggs
In a world where more than 26 million people have taken an at-home DNA test, healthcare companies are soon going to have to face a new frontier of patient expectations for security. As patients increasingly want genetic screening to be part of preventative care, healthcare systems are responding by offering DNA sequencing—but nearly all are unprepared for the demands of bio-cybersecurity. As DNA sequencing becomes more common, healthcare providers, payers, vendors, and pharmaceutical companies need to ensure that patient genetic data is secure.
Read more at CPO Magazine insights.